Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature

Neurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological abnormalities in patients receiving these antibiotic...

Full description

Bibliographic Details
Main Authors: Mohammed Al-Sadawi, Romy Rodriguez Ortega, Natalie Sun, Madina Abdurahimova, Samy I. McFarlane
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2019/8936478
id doaj-98d2670780d4434185e39f807623b3a1
record_format Article
spelling doaj-98d2670780d4434185e39f807623b3a12020-11-25T02:13:07ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352019-01-01201910.1155/2019/89364788936478Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the LiteratureMohammed Al-Sadawi0Romy Rodriguez Ortega1Natalie Sun2Madina Abdurahimova3Samy I. McFarlane4Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, NY 11203, USADepartment of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, NY 11203, USADepartment of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, NY 11203, USADepartment of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, NY 11203, USADepartment of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, NY 11203, USANeurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological abnormalities in patients receiving these antibiotics. The presence of baseline neurological abnormalities likely contributes to the frequency of these adverse events. Here, we present a case of a 78-year-old man that developed altered mental status and myoclonic movement after initiation of ceftazidime in the setting of mild renal dysfunction. Resolution of clinical picture was evident after 48 hours of discontinuation of the antibiotic without additional interventions.http://dx.doi.org/10.1155/2019/8936478
collection DOAJ
language English
format Article
sources DOAJ
author Mohammed Al-Sadawi
Romy Rodriguez Ortega
Natalie Sun
Madina Abdurahimova
Samy I. McFarlane
spellingShingle Mohammed Al-Sadawi
Romy Rodriguez Ortega
Natalie Sun
Madina Abdurahimova
Samy I. McFarlane
Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
Case Reports in Medicine
author_facet Mohammed Al-Sadawi
Romy Rodriguez Ortega
Natalie Sun
Madina Abdurahimova
Samy I. McFarlane
author_sort Mohammed Al-Sadawi
title Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
title_short Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
title_full Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
title_fullStr Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
title_full_unstemmed Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
title_sort jerky movement with ceftazidime: a case of ceftazidime-induced neurotoxicity with a review of the literature
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9627
1687-9635
publishDate 2019-01-01
description Neurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological abnormalities in patients receiving these antibiotics. The presence of baseline neurological abnormalities likely contributes to the frequency of these adverse events. Here, we present a case of a 78-year-old man that developed altered mental status and myoclonic movement after initiation of ceftazidime in the setting of mild renal dysfunction. Resolution of clinical picture was evident after 48 hours of discontinuation of the antibiotic without additional interventions.
url http://dx.doi.org/10.1155/2019/8936478
work_keys_str_mv AT mohammedalsadawi jerkymovementwithceftazidimeacaseofceftazidimeinducedneurotoxicitywithareviewoftheliterature
AT romyrodriguezortega jerkymovementwithceftazidimeacaseofceftazidimeinducedneurotoxicitywithareviewoftheliterature
AT nataliesun jerkymovementwithceftazidimeacaseofceftazidimeinducedneurotoxicitywithareviewoftheliterature
AT madinaabdurahimova jerkymovementwithceftazidimeacaseofceftazidimeinducedneurotoxicitywithareviewoftheliterature
AT samyimcfarlane jerkymovementwithceftazidimeacaseofceftazidimeinducedneurotoxicitywithareviewoftheliterature
_version_ 1724906230747496448